N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 2.466 NOK -2.14% Market Closed
Market Cap: 805.3m NOK

Wall Street
Price Targets

NYKD Price Targets Summary
Nykode Therapeutics ASA

Wall Street analysts forecast NYKD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NYKD is 5.457 NOK with a low forecast of 2.222 NOK and a high forecast of 8.925 NOK.

Lowest
Price Target
2.222 NOK
10% Downside
Average
Price Target
5.457 NOK
121% Upside
Highest
Price Target
8.925 NOK
262% Upside
Nykode Therapeutics ASA Competitors:
Price Targets
NXTC
NextCure Inc
62% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
91% Upside
IMDX
Insight Molecular Diagnostics Inc
37% Upside
397030
AprilBio Co Ltd
9% Upside
300685
Amoy Diagnostics Co Ltd
37% Upside
PGEN
Precigen Inc
135% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
43% Upside
6855
Ascentage Pharma Group International
78% Upside

Revenue
Forecast

Revenue Estimate
Nykode Therapeutics ASA

For the last 7 years the compound annual growth rate for Nykode Therapeutics ASA's revenue is 110%. The projected CAGR for the next 3 years is -47%.

110%
Past Growth
-47%
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Nykode Therapeutics ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Nykode Therapeutics ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NYKD's stock price target?
Price Target
5.457 NOK

According to Wall Street analysts, the average 1-year price target for NYKD is 5.457 NOK with a low forecast of 2.222 NOK and a high forecast of 8.925 NOK.

What is Nykode Therapeutics ASA's Revenue forecast?
Projected CAGR
-47%

For the last 7 years the compound annual growth rate for Nykode Therapeutics ASA's revenue is 110%. The projected CAGR for the next 3 years is -47%.

Back to Top